• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 病例对照宿主基因组研究设计中的统计功效。

Statistical power in COVID-19 case-control host genomic study design.

机构信息

Dalla Lana School of Public Health, University of Toronto, Room 500, 155 College St, Toronto, ON, M5T3M7, Canada.

Program in Genetics and Genome Biology, The Hospital for Sick Children, Room 12.9801, 686 Bay Street, Toronto, ON, M5G0A4, Canada.

出版信息

Genome Med. 2020 Dec 28;12(1):115. doi: 10.1186/s13073-020-00818-2.

DOI:10.1186/s13073-020-00818-2
PMID:33371892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7768597/
Abstract

The identification of genetic variation that directly impacts infection susceptibility to SARS-CoV-2 and disease severity of COVID-19 is an important step towards risk stratification, personalized treatment plans, therapeutic, and vaccine development and deployment. Given the importance of study design in infectious disease genetic epidemiology, we use simulation and draw on current estimates of exposure, infectivity, and test accuracy of COVID-19 to demonstrate the feasibility of detecting host genetic factors associated with susceptibility and severity in published COVID-19 study designs. We demonstrate that limited phenotypic data and exposure/infection information in the early stages of the pandemic significantly impact the ability to detect most genetic variants with moderate effect sizes, especially when studying susceptibility to SARS-CoV-2 infection. Our insights can aid in the interpretation of genetic findings emerging in the literature and guide the design of future host genetic studies.

摘要

鉴定直接影响 SARS-CoV-2 感染易感性和 COVID-19 疾病严重程度的遗传变异是风险分层、个性化治疗计划、治疗和疫苗开发和部署的重要步骤。鉴于传染病遗传流行病学研究设计的重要性,我们使用模拟并借鉴 COVID-19 的当前暴露、传染性和检测准确性估计,来证明在已发表的 COVID-19 研究设计中检测与易感性和严重程度相关的宿主遗传因素的可行性。我们表明,在大流行的早期阶段,有限的表型数据和暴露/感染信息会显著影响检测大多数中等效应大小的遗传变异的能力,尤其是在研究对 SARS-CoV-2 感染的易感性时。我们的见解可以帮助解释文献中出现的遗传发现,并指导未来宿主遗传研究的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/964c/7768650/006b38e73c55/13073_2020_818_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/964c/7768650/1b237292a99a/13073_2020_818_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/964c/7768650/006b38e73c55/13073_2020_818_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/964c/7768650/1b237292a99a/13073_2020_818_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/964c/7768650/006b38e73c55/13073_2020_818_Fig2_HTML.jpg

相似文献

1
Statistical power in COVID-19 case-control host genomic study design.在 COVID-19 病例对照宿主基因组研究设计中的统计功效。
Genome Med. 2020 Dec 28;12(1):115. doi: 10.1186/s13073-020-00818-2.
2
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.与 SARS-CoV-2 感染易感性和 COVID-19 疾病严重程度相关的人类遗传因素。
Hum Genomics. 2020 Oct 22;14(1):40. doi: 10.1186/s40246-020-00290-4.
3
Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.影响冠状病毒相关表型(SARS、MERS 和 COVID-19)的人类宿主遗传变异:快速系统评价和现场综述。
Hum Genomics. 2020 Sep 11;14(1):30. doi: 10.1186/s40246-020-00280-6.
4
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
5
Genomic Landscape of Susceptibility to Severe COVID-19 in the Slovenian Population.斯洛文尼亚人群中严重 COVID-19 易感性的基因组景观。
Int J Mol Sci. 2024 Jul 12;25(14):7674. doi: 10.3390/ijms25147674.
6
Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.遗传变异分析表明,在现代人类进化过程中,SARS-CoV-2 与宿主的相互作用是保守的,而在免疫反应因子方面则存在着不同的遗传适应性。
Dev Growth Differ. 2021 Apr;63(3):219-227. doi: 10.1111/dgd.12717. Epub 2021 Mar 21.
7
The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.宿主遗传学在人类严重病毒感染易感性中的作用及严重 COVID-19 的宿主遗传学见解:系统评价。
Virus Res. 2020 Nov;289:198163. doi: 10.1016/j.virusres.2020.198163. Epub 2020 Sep 9.
8
Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.与 SARS-CoV-2 感染相关的蛋白酶和先天免疫基因变异的功能预测和比较人群分析。
Infect Genet Evol. 2020 Oct;84:104498. doi: 10.1016/j.meegid.2020.104498. Epub 2020 Aug 7.
9
The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.新冠病毒宿主遗传学计划,一项旨在阐明宿主遗传因素在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒大流行的易感性和严重性中所起作用的全球倡议。
Eur J Hum Genet. 2020 Jun;28(6):715-718. doi: 10.1038/s41431-020-0636-6. Epub 2020 May 13.
10
Mapping the human genetic architecture of COVID-19.绘制人类 COVID-19 遗传结构图谱。
Nature. 2021 Dec;600(7889):472-477. doi: 10.1038/s41586-021-03767-x. Epub 2021 Jul 8.

引用本文的文献

1
Immune landscape and redox imbalance during neurological disorders in COVID-19.新冠病毒感染相关神经疾病中的免疫景观与氧化还原失衡。
Cell Death Dis. 2023 Sep 6;14(9):593. doi: 10.1038/s41419-023-06102-6.
2
HostSeq: a Canadian whole genome sequencing and clinical data resource.宿主序列:加拿大全基因组测序和临床数据资源。
BMC Genom Data. 2023 May 2;24(1):26. doi: 10.1186/s12863-023-01128-3.
3
The hidden factor: accounting for covariate effects in power and sample size computation for a binary trait.隐藏因素:在二元性状的功效和样本量计算中考虑协变量效应

本文引用的文献

1
Self-Reported Symptoms of COVID-19, Including Symptoms Most Predictive of SARS-CoV-2 Infection, Are Heritable.自我报告的 COVID-19 症状,包括最能预测 SARS-CoV-2 感染的症状,是可遗传的。
Twin Res Hum Genet. 2020 Dec;23(6):316-321. doi: 10.1017/thg.2020.85.
2
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.西班牙 2020 年人群血清流行病学研究(ENE-COVID):全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
3
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
Bioinformatics. 2023 Apr 3;39(4). doi: 10.1093/bioinformatics/btad139.
4
Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study.血清学和分子工具在新冠患者管理中的应用:GENCOV 前瞻性队列研究方案。
BMJ Open. 2021 Sep 30;11(9):e052842. doi: 10.1136/bmjopen-2021-052842.
5
Ethically utilising COVID-19 host-genomic data.道德地利用新冠病毒宿主基因组数据。
NPJ Genom Med. 2021 May 10;6(1):31. doi: 10.1038/s41525-021-00194-9.
全基因组关联研究严重新冠肺炎伴呼吸衰竭。
N Engl J Med. 2020 Oct 15;383(16):1522-1534. doi: 10.1056/NEJMoa2020283. Epub 2020 Jun 17.
4
Age-dependent effects in the transmission and control of COVID-19 epidemics.年龄相关因素对 COVID-19 疫情传播和防控的影响。
Nat Med. 2020 Aug;26(8):1205-1211. doi: 10.1038/s41591-020-0962-9. Epub 2020 Jun 16.
5
Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes.COVID-19 感染的遗传途径:对风险、严重程度和结果的影响。
FASEB J. 2020 Jul;34(7):8787-8795. doi: 10.1096/fj.202001115R. Epub 2020 Jun 11.
6
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.估算非药物干预措施对欧洲 COVID-19 疫情的影响。
Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8.
7
False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications.新型冠状病毒2型感染的假阴性检测——挑战与影响
N Engl J Med. 2020 Aug 6;383(6):e38. doi: 10.1056/NEJMp2015897. Epub 2020 Jun 5.
8
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.全球努力定义 SARS-CoV-2 感染保护性免疫的人类遗传学。
Cell. 2020 Jun 11;181(6):1194-1199. doi: 10.1016/j.cell.2020.05.016. Epub 2020 May 13.
9
The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.新冠病毒宿主遗传学计划,一项旨在阐明宿主遗传因素在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒大流行的易感性和严重性中所起作用的全球倡议。
Eur J Hum Genet. 2020 Jun;28(6):715-718. doi: 10.1038/s41431-020-0636-6. Epub 2020 May 13.
10
Interpreting a covid-19 test result.解读新冠病毒检测结果。
BMJ. 2020 May 12;369:m1808. doi: 10.1136/bmj.m1808.